Viropro Inc.

Viropro Inc.

VPRO - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$25.4K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Viropro Inc.Viropro Inc.0--11%-0.6

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$25,404.00
Enterprise Value$11.96 Million
Earnings per Share$-0.01
Beta3.77
Outstanding Shares896,057,587

Return

Return on Equity-10.61%ROE
Return on Assets-5.79%
Return on Invested Capital-5.64%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue11.8
Enterprise Value to EBIT-5.96
Enterprise Value to Net Income-6
Total Debt to Enterprise1.01
Debt to Equity0.57Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Viropro Inc.

0
CEO: Michelle Leanne Edythe Peake

Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract research and manufacturing organization (CRMO), primarily engaged in the development and production of biotherapeutic proteins aimed at treating diverse medic...